Normalina Sandora
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Normalina Sandora has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
Chaidar Muttaqin
4 shared publicationsIdrus Alwi
Division of Cardiology, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Jakarta, 10430, Indonesia
4 shared publicationsNur Amalina Fitria
Indonesian Medical Education and Research Institute, Universitas Indonesia, Jakarta, 10430, Indonesia
4 shared publicationsTyas Rahmah Kusuma
Indonesian Medical Education and Research Institute, Universitas Indonesia, Jakarta, 10430, Indonesia
4 shared publicationsWilliam Makdinata
4 shared publicationsArdiansyah
Department of Cardiovascular and Thoracic Surgery, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia
3 shared publications
Latest Publications
- Open Access
- 29 September 2025
- Published by Jurnal Plastik Rekonstruksi in Jurnal Plastik Rekonstruksi
- Vol. 12 (2) , 97-108
Current Updates of Biomaterials for Skin Replacement: A Systematic Review
Background: The human skin envelops the entire body surface and is highly susceptible to damage. Partial- and full-thickness skin loss often necessitates the use of skin substitutes. Autologous grafting remains the gold standard for skin replacement. Furthermore, the application is usually constrained by the limited availability of donor skin, the technical challenges of surgery, and the added difficulties encountered in severe cases. In this systematic review, we summarise the strengths and limitations of biological and synthetic biomaterials as skin substitutes, with evidence drawn from clinical practice, human trials, and preclinical animal studies. This systematic review evaluates the advantages and disadvantages of biological and synthetic biomaterials used as skin substitutes, drawing evidence from clinical practice, human studies, and animal studies.”Method: We performed a comprehensive literature review using the search engines OVID, ScienceDirect, Google Scholar, and PubMed databases. Search terms or keywords included "artificial skin," "biomaterials," "skin substitute," "full-thickness burn," "synthetic materials," "burn graft materials," and "wound care." From an initial pool of 97 articles, 65 met the inclusion criteria, which required peer-reviewed studies published in English after 2000, focusing on biomaterials for skin substitutes evaluated in clinical, human, or animal studies.Results: Skin substitutes commercially available in the market were predominantly incorporated with human fibroblasts and keratinocytes within a three-dimensional matrix, with a preference for biological materials due to their biocompatibility. Nevertheless, biological substitutes face challenges such as limited availability, extended production time, high costs, and lack of immediate usability. In contrast, synthetic substitutes are more accessible and scalable but often do not integrate well with the recipient's tissue, which limits their clinical efficacy.Conclusion: While both biological and synthetic artificial skin substitutes are available on the market, none of the current options fully meet the ideal criteria for skin replacement, such as affordability, availability, seamless integration with the surrounding tissue, and the ability to minimise scarring. More research is needed to address these limitations and advance the development of next-generation biomaterials that can effectively replace skin.
- 29 September 2025
- Published by Jurnal Plastik Rekonstruksi in Jurnal Plastik Rekonstruksi
- Vol. 12 (2) , 97-108
Open AccessCurrent Updates of Biomaterials for Skin Replacement: A Systematic Review
Background: The human skin envelops the entire body surface and is highly susceptible to damage. Partial- and full-thickness skin loss often necessitates the use of skin substitutes. Autologous grafting remains the gold standard for skin replacement. Furthermore, the application is usually constrained by the limited availability of donor skin, the technical challenges of surgery, and the added difficulties encountered in severe cases. In this systematic review, we summarise the strengths and limitations of biological and synthetic biomaterials as skin substitutes, with evidence drawn from clinical practice, human trials, and preclinical animal studies. This systematic review evaluates the advantages and disadvantages of biological and synthetic biomaterials used as skin substitutes, drawing evidence from clinical practice, human studies, and animal studies.”Method: We performed a comprehensive literature review using the search engines OVID, ScienceDirect, Google Scholar, and PubMed databases. Search terms or keywords included "artificial skin," "biomaterials," "skin substitute," "full-thickness burn," "synthetic materials," "burn graft materials," and "wound care." From an initial pool of 97 articles, 65 met the inclusion criteria, which required peer-reviewed studies published in English after 2000, focusing on biomaterials for skin substitutes evaluated in clinical, human, or animal studies.Results: Skin substitutes commercially available in the market were predominantly incorporated with human fibroblasts and keratinocytes within a three-dimensional matrix, with a preference for biological materials due to their biocompatibility. Nevertheless, biological substitutes face challenges such as limited availability, extended production time, high costs, and lack of immediate usability. In contrast, synthetic substitutes are more accessible and scalable but often do not integrate well with the recipient's tissue, which limits their clinical efficacy.Conclusion: While both biological and synthetic artificial skin substitutes are available on the market, none of the current options fully meet the ideal criteria for skin replacement, such as affordability, availability, seamless integration with the surrounding tissue, and the ability to minimise scarring. More research is needed to address these limitations and advance the development of next-generation biomaterials that can effectively replace skin.
- 14 August 2025
- Published by CSIRO Publishing in Reproduction, Fertility and Development
- Vol. 37 (13)
Reconstruction of endometrial histoarchitecture and receptivity genes in Asherman’s syndrome patients using a 3D acellular amnion bilayer scaffold seeded with endometrial cells
Context: Thin endometrium with Asherman’s syndrome is a challenge in in vitro fertilisation, as patients cannot conceive even if the embryo is well. Aims: This study aimed to regenerate thin endometria unresponsive to treatments, using autologous endometrial cells and acellular amnion bilayer as a womb patch. Methods: This preliminary quasi-experimental study investigated thin endometria before and after intervention with an amnion bilayer (AB) and AB with self-endometrial cells (AB + Cells). Patients were IVF candidates with oligomenorrhea, endometrial thickness (EMT) < 7 mm, unresponsive towards hormonal treatment, and three courses of platelet-rich plasma applications. Intervention responses were indicated by (i) EMT measurement, (ii) endometrial cell epitopes, (iii) histoarchitecture and immunohistochemistry, and (iv) relative expression of the endometrial receptivity genes. Key results: Average EMT increased significantly from 5.03 ± 0.95 mm to 6.75 ± 1.39 mm after AB, and further to 7.33 ± 1.92 mm after AB + Cells. Cell density was significantly higher after AB + Cells. The histoarchitecture after AB + Cells developed into a complex tubular system, and E-cadherin and oestrogen receptor alpha (ER-α) was detected. Homeobox A10 (HOXA10) expression increased significantly, up to 4.5-fold after AB + Cells treatment compared with before treatment (P = 0.01), while leukaemia inhibitory factor (LIF) and osteopontin (SPP1) levels also increased, but not significantly. Significant changes in gene expression and cell populations were observed, with improvements in receptivity genes. Conclusions: Patients with thin endometria showed improvement in EMT, histoarchitecture, and receptivity genes after AB and AB + Cells intervention. Implications: The study demonstrates the potential of using a 3D amnion bilayer scaffold with endometrial cells to improve endometrial regeneration.
- 14 August 2025
- Published by CSIRO Publishing in Reproduction, Fertility and Development
- Vol. 37 (13)
Reconstruction of endometrial histoarchitecture and receptivity genes in Asherman’s syndrome patients using a 3D acellular amnion bilayer scaffold seeded with endometrial cells
Context: Thin endometrium with Asherman’s syndrome is a challenge in in vitro fertilisation, as patients cannot conceive even if the embryo is well. Aims: This study aimed to regenerate thin endometria unresponsive to treatments, using autologous endometrial cells and acellular amnion bilayer as a womb patch. Methods: This preliminary quasi-experimental study investigated thin endometria before and after intervention with an amnion bilayer (AB) and AB with self-endometrial cells (AB + Cells). Patients were IVF candidates with oligomenorrhea, endometrial thickness (EMT) < 7 mm, unresponsive towards hormonal treatment, and three courses of platelet-rich plasma applications. Intervention responses were indicated by (i) EMT measurement, (ii) endometrial cell epitopes, (iii) histoarchitecture and immunohistochemistry, and (iv) relative expression of the endometrial receptivity genes. Key results: Average EMT increased significantly from 5.03 ± 0.95 mm to 6.75 ± 1.39 mm after AB, and further to 7.33 ± 1.92 mm after AB + Cells. Cell density was significantly higher after AB + Cells. The histoarchitecture after AB + Cells developed into a complex tubular system, and E-cadherin and oestrogen receptor alpha (ER-α) was detected. Homeobox A10 (HOXA10) expression increased significantly, up to 4.5-fold after AB + Cells treatment compared with before treatment (P = 0.01), while leukaemia inhibitory factor (LIF) and osteopontin (SPP1) levels also increased, but not significantly. Significant changes in gene expression and cell populations were observed, with improvements in receptivity genes. Conclusions: Patients with thin endometria showed improvement in EMT, histoarchitecture, and receptivity genes after AB and AB + Cells intervention. Implications: The study demonstrates the potential of using a 3D amnion bilayer scaffold with endometrial cells to improve endometrial regeneration.
- Open Access
- 1 August 2025
- Published by Academia.edu in Academia Biology
- Vol. 3 (3)
Cellular, histological, and gene expression differences in thin versus normal endometrium
Background: Endometrium disorders cause significant failure in fertility. Our study aimed to investigate the cellular, histological, and molecular properties of patients with thin endometrium compared to healthy endometrium without pathological conditions (n = 6). Methods: This study was a randomized control (n = 6) in which samples of thin endometrium were obtained from IVF patients enrolled in the IVF clinic in the National Hospital Ciptomangunkusumo, Jakarta, Indonesia, from 2018 to 2019. The typical samples were taken from patients who underwent tubectomy with no pathological findings in the endometrium. Endometrial cells were isolated using an enzymatic method transported in medium, PCR samples were used in an RNA solution, and histology samples were stored in neutral-buffered formalin 10% (v/v). Results: The number of cells, presented as density of cells mg−1 wet weight during endometrial biopsy, was about 10,190 cells mg−1 wet weight in the healthy-endometrium group, while the thin-endometrium group had 3305 cells mg−1 wet weight. A flow cytometry analysis of the endometrial in the healthy group showed all panels were significantly higher compared to the thin group: BCRP1/Breast Cancer-Resistant Protein (74.85 ± 15.63% vs. 15.58 ± 7.19%), ICAM-1/Intercellular Adhesion Molecule or CD54 (35.76 ± 6.23% vs. 7.24 ± 1.65%), PECAM/platelet endothelial cell adhesion molecule-1 or CD31 (29.42 ± 2.16% vs. 4.19 ± 2.03%), and cKit/type III receptor tyrosine kinase or CD117 (27.29 ± 1.93% vs. 5.32 ± 2.38%). The exception was SUSD-2/Sushi Domain Containing Protein-2, although these results were insignificant (1.33 ± 0.39% vs. 0.26 ± 0.39%, respectively) (mean ± 95% C.l). Endometrial receptivity, indicated by HOXA10/Homeobox protein-10, LIF/Leukemia inhibitory factor, SPP1/osteopontin, and VEGF/Vascular Endothelial Growth Factor, was significantly higher in the healthy group compared to the thin group. Immunohistochemical labelling showed that E-cadherin, estrogen/ER-α, and progesterone receptors/PR were found in healthy-endometrium patients while they were less expressed among thin-endometrium patients. Conclusions: Patients with healthy endometrium had significantly higher cell numbers per mg, significantly higher endometrial and endothelial cells, and expressed higher receptivity genes than patients with thin endometrium, although the SUSD-2-positive cells showed no difference.
- 1 August 2025
- Published by Academia.edu in Academia Biology
- Vol. 3 (3)
Open AccessCellular, histological, and gene expression differences in thin versus normal endometrium
Background: Endometrium disorders cause significant failure in fertility. Our study aimed to investigate the cellular, histological, and molecular properties of patients with thin endometrium compared to healthy endometrium without pathological conditions (n = 6). Methods: This study was a randomized control (n = 6) in which samples of thin endometrium were obtained from IVF patients enrolled in the IVF clinic in the National Hospital Ciptomangunkusumo, Jakarta, Indonesia, from 2018 to 2019. The typical samples were taken from patients who underwent tubectomy with no pathological findings in the endometrium. Endometrial cells were isolated using an enzymatic method transported in medium, PCR samples were used in an RNA solution, and histology samples were stored in neutral-buffered formalin 10% (v/v). Results: The number of cells, presented as density of cells mg−1 wet weight during endometrial biopsy, was about 10,190 cells mg−1 wet weight in the healthy-endometrium group, while the thin-endometrium group had 3305 cells mg−1 wet weight. A flow cytometry analysis of the endometrial in the healthy group showed all panels were significantly higher compared to the thin group: BCRP1/Breast Cancer-Resistant Protein (74.85 ± 15.63% vs. 15.58 ± 7.19%), ICAM-1/Intercellular Adhesion Molecule or CD54 (35.76 ± 6.23% vs. 7.24 ± 1.65%), PECAM/platelet endothelial cell adhesion molecule-1 or CD31 (29.42 ± 2.16% vs. 4.19 ± 2.03%), and cKit/type III receptor tyrosine kinase or CD117 (27.29 ± 1.93% vs. 5.32 ± 2.38%). The exception was SUSD-2/Sushi Domain Containing Protein-2, although these results were insignificant (1.33 ± 0.39% vs. 0.26 ± 0.39%, respectively) (mean ± 95% C.l). Endometrial receptivity, indicated by HOXA10/Homeobox protein-10, LIF/Leukemia inhibitory factor, SPP1/osteopontin, and VEGF/Vascular Endothelial Growth Factor, was significantly higher in the healthy group compared to the thin group. Immunohistochemical labelling showed that E-cadherin, estrogen/ER-α, and progesterone receptors/PR were found in healthy-endometrium patients while they were less expressed among thin-endometrium patients. Conclusions: Patients with healthy endometrium had significantly higher cell numbers per mg, significantly higher endometrial and endothelial cells, and expressed higher receptivity genes than patients with thin endometrium, although the SUSD-2-positive cells showed no difference.
- Open Access
- 9 May 2025
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 20 (1) , 1-20
Cocultured amniotic stem cells and cardiomyocytes in a 3-D acellular heart patch reduce the infarct size and left ventricle remodeling: promote angiogenesis in a porcine acute myocardial infarction model
Acute myocardial infarction (AMI) induces significant myocardial damage, ultimately leading to heart failure as the surrounding healthy myocardial tissue undergoes progressive deterioration due to excessive mechanical stress. This study aimed to investigate myocardial regeneration in a porcine model of AMI using an acellular amniotic membrane with fibrin—termed an amnion bilayer (AB) or heart patch—as a cellular delivery system using porcine amniotic stem cells (pASCs) and autologous porcine cardiomyocytes (pCardios). Fifteen pigs (aged 2–4 months, weighing 50–60 kg) were randomly assigned to three experimental groups (n = 5): control group (AMI induction only), pASC group (pASC transplantation only), and coculture group (pASC and pCardio transplantation). AMI was induced via posterior left ventricular artery ligation and confirmed through standard biomarkers. After eight weeks, histological and molecular analyses were conducted to assess myocardial regeneration. Improvement in regional wall motion abnormality (RWMA) was observed in 60% of the coculture group, 25% of the pASC group, and none in the control group. Histological analysis of the control group revealed extensive fibrosis with pronounced lipomatosis, particularly at the infarct center. In contrast, pASC and coculture groups exhibited minimal fibrotic scarring at both the infarct center and border regions. Immunofluorescence analysis demonstrated positive α-actinin expression in both the pASC and coculture groups, with the coculture group displaying sarcomeric structures—an organization absent in control group. RNA expression levels of key cardiomyogenic markers, including cardiac troponin T (cTnT), myosin heavy chain (MHC), and Nkx2.5, were significantly elevated in the treatment groups compared to the controls, with the coculture group exhibiting the highest MHC expression. The expression of c-Kit was also increased in both treatment groups relative to the control. Conversely, apoptotic markers p21 and Caspase-9 were highest in the control group, while coculture group exhibited the lowest p53 expression. Epicardial transplantation of an acellular amniotic heart patch cocultured with cardiomyocytes and pASCs demonstrated superior cardiomyogenesis after eight weeks compared to pASC transplantation alone or control conditions. The coculture system was found to enhance the cardiac regeneration process, as evidenced by improved RWMA, distinct sarcomeric organization, reduced fibrotic scarring, and lower apoptotic gene expression.
- 9 May 2025
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 20 (1) , 1-20
Open AccessCocultured amniotic stem cells and cardiomyocytes in a 3-D acellular heart patch reduce the infarct size and left ventricle remodeling: promote angiogenesis in a porcine acute myocardial infarction model
Acute myocardial infarction (AMI) induces significant myocardial damage, ultimately leading to heart failure as the surrounding healthy myocardial tissue undergoes progressive deterioration due to excessive mechanical stress. This study aimed to investigate myocardial regeneration in a porcine model of AMI using an acellular amniotic membrane with fibrin—termed an amnion bilayer (AB) or heart patch—as a cellular delivery system using porcine amniotic stem cells (pASCs) and autologous porcine cardiomyocytes (pCardios). Fifteen pigs (aged 2–4 months, weighing 50–60 kg) were randomly assigned to three experimental groups (n = 5): control group (AMI induction only), pASC group (pASC transplantation only), and coculture group (pASC and pCardio transplantation). AMI was induced via posterior left ventricular artery ligation and confirmed through standard biomarkers. After eight weeks, histological and molecular analyses were conducted to assess myocardial regeneration. Improvement in regional wall motion abnormality (RWMA) was observed in 60% of the coculture group, 25% of the pASC group, and none in the control group. Histological analysis of the control group revealed extensive fibrosis with pronounced lipomatosis, particularly at the infarct center. In contrast, pASC and coculture groups exhibited minimal fibrotic scarring at both the infarct center and border regions. Immunofluorescence analysis demonstrated positive α-actinin expression in both the pASC and coculture groups, with the coculture group displaying sarcomeric structures—an organization absent in control group. RNA expression levels of key cardiomyogenic markers, including cardiac troponin T (cTnT), myosin heavy chain (MHC), and Nkx2.5, were significantly elevated in the treatment groups compared to the controls, with the coculture group exhibiting the highest MHC expression. The expression of c-Kit was also increased in both treatment groups relative to the control. Conversely, apoptotic markers p21 and Caspase-9 were highest in the control group, while coculture group exhibited the lowest p53 expression. Epicardial transplantation of an acellular amniotic heart patch cocultured with cardiomyocytes and pASCs demonstrated superior cardiomyogenesis after eight weeks compared to pASC transplantation alone or control conditions. The coculture system was found to enhance the cardiac regeneration process, as evidenced by improved RWMA, distinct sarcomeric organization, reduced fibrotic scarring, and lower apoptotic gene expression.
- Open Access
- 15 February 2025
- Published by Jurnal Plastik Rekonstruksi in Jurnal Plastik Rekonstruksi
- Vol. 12 (1) , 14-29
Analyzing The Efficacy and Outcome of Amniotic Membrane in Burn Care: A Systematic Review and Meta-Analysis
Introduction: Managing burn injuries is a significant clinical challenge in promoting wound healing and minimizing complications. Advances like amniotic membrane as a biological dressing have been introduced to improve wound healing. This study analyzes the efficacy of amniotic membrane in burn care and its impact on wound healing outcomes.Methods: We conducted a systematic review in Pubmed, Cochrane, and ScienceDirect, using “Amnion”, “Burns”, and “Wound healing” as keywords. The inclusion criteria are studies assessing the application of amniotic membrane on burn wounds. The outcome measures were mean healing time, wound healing rate, incidence of wound infection, dressing renewal frequency, pain score, and LOS.Results: We identified eleven trials (n=971) ranging from the year 1989 to 2023, containing eight RCTs, and three NRCTs. The pooled RR showed statistically significant differences between amniotic membrane group and control group in mean healing time (RR -4.52 [95% CI; -6.93, -2.11]; p=0.0002), wound healing rate (RR 1.60 [95% CI; 1.09, 2.33]; p=0.02), incidence of wound infection (RR 0.48 [95% CI; 0.30, 0.77]; p=0.002), and dressing renewal frequency (RR -1.64 [95% CI; -2.48, -0.79]; p=0.0002).Conclusion: This meta-analysis indicates that amniotic membrane is advantageous as a biological dressing for burn patients.
- 15 February 2025
- Published by Jurnal Plastik Rekonstruksi in Jurnal Plastik Rekonstruksi
- Vol. 12 (1) , 14-29
Open AccessAnalyzing The Efficacy and Outcome of Amniotic Membrane in Burn Care: A Systematic Review and Meta-Analysis
Introduction: Managing burn injuries is a significant clinical challenge in promoting wound healing and minimizing complications. Advances like amniotic membrane as a biological dressing have been introduced to improve wound healing. This study analyzes the efficacy of amniotic membrane in burn care and its impact on wound healing outcomes.Methods: We conducted a systematic review in Pubmed, Cochrane, and ScienceDirect, using “Amnion”, “Burns”, and “Wound healing” as keywords. The inclusion criteria are studies assessing the application of amniotic membrane on burn wounds. The outcome measures were mean healing time, wound healing rate, incidence of wound infection, dressing renewal frequency, pain score, and LOS.Results: We identified eleven trials (n=971) ranging from the year 1989 to 2023, containing eight RCTs, and three NRCTs. The pooled RR showed statistically significant differences between amniotic membrane group and control group in mean healing time (RR -4.52 [95% CI; -6.93, -2.11]; p=0.0002), wound healing rate (RR 1.60 [95% CI; 1.09, 2.33]; p=0.02), incidence of wound infection (RR 0.48 [95% CI; 0.30, 0.77]; p=0.002), and dressing renewal frequency (RR -1.64 [95% CI; -2.48, -0.79]; p=0.0002).Conclusion: This meta-analysis indicates that amniotic membrane is advantageous as a biological dressing for burn patients.
- 7 January 2022
- Published by Springer Nature in Cell and Tissue Banking
- Vol. 23 (4) , 717-727
Transport viable heart tissue at physiological temperature yielded higher human cardiomyocytes compared to the conventional temperature
This study investigated the optimum transport condition for heart tissue to recover single-cell cardiomyocytes for future in-vitro or in-vivo studies. The heart tissues were obtained from removing excessive myocardium discharged during the repair surgery of an excessive right atrial hypertrophy due to a congenital disease. The transportation temperature studied was the most used temperature (4 °C) or the conventional condition, compared to a physiological temperature(37 °C). The heart tissues were transported from the operating theatre to the lab maintained less than 30 min consistently. Single-cell isolation was enzymatically and mechanically performed using collagenase-V (160 U/mg) and proteinase-XXIV (7-14 U/mg) following the previously described protocol. The impact of temperature differences was observed by the density of cells harvested per mg tissue, cell viability, and the senescence signals, identified by the p21, p53 and caspase-9 mRNA expressions. Results the heart tissue transported at 37 °C yielded significantly higher viable cell density (p < 0.01) yielded viable cells significantly higher density (p < 0.01) than the 4 °C; 2,335 ± 849 cells per mg tissue, and 732 ± 425 cells per mg tissue, respectively. The percentage of viable cells in both groups showed no difference. Although the 37 °C group expressed the apoptosis genes such as p21, p53 and caspase9 by 2.5-, 5.41-, 5-fold respectively (p > 0.05). Nonetheless, the Nk×2.5 and MHC genes were expressed 1,7- and 3.56-fold higher than the 4 °C. and the c-Kit+ expression was 17.56-fold, however, statistically insignificant. Conclusion When needed for single-cell isolation, a heart tissue transported at 37 °C yielded higher cell density per mg tissue compared to at 4 °C, while other indicators of gene expressions for apoptosis, cardiac structural proteins, cardiac progenitor cells showed no difference. Further investigations of the isolated cells at different temperature conditions towards their proliferation and differentiation capacities in a 3-D scaffold would be essential.
- 7 January 2022
- Published by Springer Nature in Cell and Tissue Banking
- Vol. 23 (4) , 717-727
Transport viable heart tissue at physiological temperature yielded higher human cardiomyocytes compared to the conventional temperature
This study investigated the optimum transport condition for heart tissue to recover single-cell cardiomyocytes for future in-vitro or in-vivo studies. The heart tissues were obtained from removing excessive myocardium discharged during the repair surgery of an excessive right atrial hypertrophy due to a congenital disease. The transportation temperature studied was the most used temperature (4 °C) or the conventional condition, compared to a physiological temperature(37 °C). The heart tissues were transported from the operating theatre to the lab maintained less than 30 min consistently. Single-cell isolation was enzymatically and mechanically performed using collagenase-V (160 U/mg) and proteinase-XXIV (7-14 U/mg) following the previously described protocol. The impact of temperature differences was observed by the density of cells harvested per mg tissue, cell viability, and the senescence signals, identified by the p21, p53 and caspase-9 mRNA expressions. Results the heart tissue transported at 37 °C yielded significantly higher viable cell density (p < 0.01) yielded viable cells significantly higher density (p < 0.01) than the 4 °C; 2,335 ± 849 cells per mg tissue, and 732 ± 425 cells per mg tissue, respectively. The percentage of viable cells in both groups showed no difference. Although the 37 °C group expressed the apoptosis genes such as p21, p53 and caspase9 by 2.5-, 5.41-, 5-fold respectively (p > 0.05). Nonetheless, the Nk×2.5 and MHC genes were expressed 1,7- and 3.56-fold higher than the 4 °C. and the c-Kit+ expression was 17.56-fold, however, statistically insignificant. Conclusion When needed for single-cell isolation, a heart tissue transported at 37 °C yielded higher cell density per mg tissue compared to at 4 °C, while other indicators of gene expressions for apoptosis, cardiac structural proteins, cardiac progenitor cells showed no difference. Further investigations of the isolated cells at different temperature conditions towards their proliferation and differentiation capacities in a 3-D scaffold would be essential.
- 28 October 2021
- Published by Springer Nature in Cell and Tissue Banking
- Vol. 23 (3) , 489-497
Characterisation of the single-cell human cardiomyocytes taken from the excess heart tissue of the right ventricular outlet in congenital heart disease
Cardiovascular disease is the second highest cause of death across the globe. Myocardial infarction is one of the heart diseases that cause permanent impairment of the heart wall leads to heart failure. Cellular therapy might give hope to regenerate the damaged myocardium. Single cells isolated from an excess heart tissue obtained from the correction of the right ventricular hypertrophy in patients with Tetralogy of Fallot for future heart study were investigated. Methods: Once resected, the heart tissues were transported at 37 °C, in Dulbecco's Modified Eagle's medium/ DMEM (4.5 g.L−1, antibiotic–antimycotic 3x, PRP10% (v/v)), to reach the lab within 30 min, weighted and grouped into less than 500 mg and more than 1000 mg (n = 4). Each sample was digested with 250 U.mL−1 Collagenase type V and 4U.mL−1 Proteinase XXIV in the MACS™ C-tube (Milltenyi, Germany), then dissociated using the MACS™ Octo Dissociator with Heater (Milltenyi, Germany) for 60 min at 37 °C. Results: All cells isolated were rod-shaped cells; viability was up to 90%. The cell density obtained from the 500 mg group were 4,867 ± 899 cells.mg−1 tissue weight, significantly higher compared to the 1,000 mg group; had 557 ± 490 cells.mg−1 tissue weight (mean of (n = 3) ± 95% C.l). The isolated cells were analyzed using FACs BD Flowcytometer, expressed cTnT + 13.38%, PECAM-1 + /VCAM-1- 32.25%, cKit + 7.85%, ICAM + 85.53%, indicating the cardiomyocyte progenitor cells. Conclusion: Cardiomyocytes taken from the wasted heart tissue might be a candidate of cardiomyocytes source to study interventions to the heart as it contained up to 13.38% cardiomyocytes, and 32.25% of cardiac progenitor cells. Moreover, perhaps when cardiac cell therapy needs autologous cardiomyocytes, less than 500 mg tissue weight can be considered as sufficient.
- 28 October 2021
- Published by Springer Nature in Cell and Tissue Banking
- Vol. 23 (3) , 489-497
Characterisation of the single-cell human cardiomyocytes taken from the excess heart tissue of the right ventricular outlet in congenital heart disease
Cardiovascular disease is the second highest cause of death across the globe. Myocardial infarction is one of the heart diseases that cause permanent impairment of the heart wall leads to heart failure. Cellular therapy might give hope to regenerate the damaged myocardium. Single cells isolated from an excess heart tissue obtained from the correction of the right ventricular hypertrophy in patients with Tetralogy of Fallot for future heart study were investigated. Methods: Once resected, the heart tissues were transported at 37 °C, in Dulbecco's Modified Eagle's medium/ DMEM (4.5 g.L−1, antibiotic–antimycotic 3x, PRP10% (v/v)), to reach the lab within 30 min, weighted and grouped into less than 500 mg and more than 1000 mg (n = 4). Each sample was digested with 250 U.mL−1 Collagenase type V and 4U.mL−1 Proteinase XXIV in the MACS™ C-tube (Milltenyi, Germany), then dissociated using the MACS™ Octo Dissociator with Heater (Milltenyi, Germany) for 60 min at 37 °C. Results: All cells isolated were rod-shaped cells; viability was up to 90%. The cell density obtained from the 500 mg group were 4,867 ± 899 cells.mg−1 tissue weight, significantly higher compared to the 1,000 mg group; had 557 ± 490 cells.mg−1 tissue weight (mean of (n = 3) ± 95% C.l). The isolated cells were analyzed using FACs BD Flowcytometer, expressed cTnT + 13.38%, PECAM-1 + /VCAM-1- 32.25%, cKit + 7.85%, ICAM + 85.53%, indicating the cardiomyocyte progenitor cells. Conclusion: Cardiomyocytes taken from the wasted heart tissue might be a candidate of cardiomyocytes source to study interventions to the heart as it contained up to 13.38% cardiomyocytes, and 32.25% of cardiac progenitor cells. Moreover, perhaps when cardiac cell therapy needs autologous cardiomyocytes, less than 500 mg tissue weight can be considered as sufficient.
- 28 July 2021
- Published by Springer Nature in Cardiovascular Engineering and Technology
- Vol. 13 (2) , 193-206
Preparation of Cell-Seeded Heart Patch In Vitro; Co-Culture of Adipose-Derived Mesenchymal Stem Cell and Cardiomyocytes in Amnion Bilayer Patch
Introduction Cardiovascular disease is the second killer across the globe, while coronary disease is the major cause. Cell therapy is one alternative to regenerate the infarcted heart wall. Materials and Methods In this study, the cardiomyogenesis capacity of human adipose stem cells (hAdSC) and human cardiomyocytes (hCardio) cultured in a 3-D biological scaffold (decellularised amnion bilayer) for nine days in a static condition was investigated. The cardiomyogenesis capacity of hAdSC were identified using immunohistochemistry and RT-PCR. The population of the cells isolated from the heart tissue expressed cTnT-1 (13.38 ± 11.38%), cKit (7.85 ± 4.2%), ICAM (85.53 ± 8.69%), PECAM (61.63 ± 7.18%) and VCAM (35.9 ± 9.11%), while from the fat tissue expressed the mesenchymal phenotypes (CD73, CD90, CD105, but not CD45, CD34, CD11b, CD19 and HLA-DR). Two age groups of hAdSC donors were compared, the youngsters (30-40yo) and the elderly (60–70 yo). Results The co-culture showed that after 5-day incubation, the seeded graft in the hAdSC-30 group had a tube-like appearance while the hAdSC-60 group demonstrated a disorganised pattern, despite of the MSC expressions of the hAdSC-60 were significantly higher. Initial co-culture showed no difference of ATP counts among all groups, however the hAdSC-30 group had the highest ATP count after 9 days culture (p = 0.004). After normalising to the normal myocardium, only the hAdSC-60 group expressed cTnT and MHC, very low, seen during the initial cultivation, but then disappeared. Meanwhile, the hAdSC-30 group expressed α-actinin, MHC and cTnT in the Day-5. The PPAR also was higher in the Day-5 compared to the Day-9 (p < 0.005). Conclusion Cardiomyogenesis capacity of hAdSC co-cultured with hCardio in a 3-D scaffold taken from the 30–40yo donor showed better morphology and viability than the 60-70yo group, but maintained less than 5 days in this system.
- 28 July 2021
- Published by Springer Nature in Cardiovascular Engineering and Technology
- Vol. 13 (2) , 193-206
Preparation of Cell-Seeded Heart Patch In Vitro; Co-Culture of Adipose-Derived Mesenchymal Stem Cell and Cardiomyocytes in Amnion Bilayer Patch
Introduction Cardiovascular disease is the second killer across the globe, while coronary disease is the major cause. Cell therapy is one alternative to regenerate the infarcted heart wall. Materials and Methods In this study, the cardiomyogenesis capacity of human adipose stem cells (hAdSC) and human cardiomyocytes (hCardio) cultured in a 3-D biological scaffold (decellularised amnion bilayer) for nine days in a static condition was investigated. The cardiomyogenesis capacity of hAdSC were identified using immunohistochemistry and RT-PCR. The population of the cells isolated from the heart tissue expressed cTnT-1 (13.38 ± 11.38%), cKit (7.85 ± 4.2%), ICAM (85.53 ± 8.69%), PECAM (61.63 ± 7.18%) and VCAM (35.9 ± 9.11%), while from the fat tissue expressed the mesenchymal phenotypes (CD73, CD90, CD105, but not CD45, CD34, CD11b, CD19 and HLA-DR). Two age groups of hAdSC donors were compared, the youngsters (30-40yo) and the elderly (60–70 yo). Results The co-culture showed that after 5-day incubation, the seeded graft in the hAdSC-30 group had a tube-like appearance while the hAdSC-60 group demonstrated a disorganised pattern, despite of the MSC expressions of the hAdSC-60 were significantly higher. Initial co-culture showed no difference of ATP counts among all groups, however the hAdSC-30 group had the highest ATP count after 9 days culture (p = 0.004). After normalising to the normal myocardium, only the hAdSC-60 group expressed cTnT and MHC, very low, seen during the initial cultivation, but then disappeared. Meanwhile, the hAdSC-30 group expressed α-actinin, MHC and cTnT in the Day-5. The PPAR also was higher in the Day-5 compared to the Day-9 (p < 0.005). Conclusion Cardiomyogenesis capacity of hAdSC co-cultured with hCardio in a 3-D scaffold taken from the 30–40yo donor showed better morphology and viability than the 60-70yo group, but maintained less than 5 days in this system.
- Open Access
- 1 August 2018
- Published by IOP Publishing in Journal of Physics: Conference Series
- Vol. 1073 (3) , 032053
Histoanalysis and sterility assay of fresh human amniotic membrane for use in urogynecology
- 1 August 2018
- Published by IOP Publishing in Journal of Physics: Conference Series
- Vol. 1073 (3) , 032053
Open AccessHistoanalysis and sterility assay of fresh human amniotic membrane for use in urogynecology